NCT06340607View on ClinicalTrials.gov

Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients

CompletedOBSERVATIONAL
Enrollment

3,422

Participants

Timeline

Start Date

January 5, 2012

Primary Completion Date

January 5, 2020

Study Completion Date

December 31, 2022

Conditions
Acute Kidney InjuryChronic Kidney DiseasesGraft Failure
Trial Locations (1)

05500

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT06340607 - Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients | Biotech Hunter | Biotech Hunter